Carillon Tower Advisers’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-20,870
Closed -$8.09M – 457
2020
Q2
$8.09M Sell
20,870
-46,881
-69% -$17.5M 0.06% 317
2020
Q1
$21.3M Buy
67,751
+10,121
+18% +$3.41M 0.21% 168
2019
Q4
$21.1M Buy
57,630
+33,788
+142% +$10.7M 0.14% 246
2019
Q3
$6.1M Sell
23,842
-30,301
-56% -$8.5M 0.04% 378
2019
Q2
$14.4M Buy
54,143
+44,354
+453% +$11.2M 0.1% 287
2019
Q1
$2.6M Sell
9,789
-17,371
-64% -$5.01M 0.02% 440
2018
Q4
$7.78M Hold
27,160
– – 0.07% 326
2018
Q3
$9.19M Buy
27,160
+168
+0.6% +$54.6K 0.07% 343
2018
Q2
$8.03M Sell
26,992
-6,387
-19% -$1.87M 0.06% 338
2018
Q1
$8.97M Buy
+33,379
New +$9.04M 0.07% 318

Other funds holding HUM

Carillon Tower Advisers's HUM Position: Q3 2020 in Review

Carillon Tower Advisers sold out of Humana (HUM) in Q3 2020, closing a stake of 20,870 shares — an estimated $8.09M sold.

Carillon Tower Advisers first reported a position in HUM in Q1 2018 and held it in 10 quarters. The position peaked at $21.3M in Q1 2020. 847 funds tracked by Wall St. Rank hold HUM as of Q3 2020.

  • Carillon Tower Advisers reported no remaining Humana position as of Q3 2020 after selling out during the quarter.
  • Carillon Tower Advisers sold 20,870 Humana shares in Q3 2020, an estimated $8.09M.
  • Carillon Tower Advisers first reported a position in Humana in Q1 2018 and held it in 10 quarters.
  • Carillon Tower Advisers's Humana position peaked at $21.3M in Q1 2020.
  • 847 funds tracked by Wall St. Rank held Humana as of Q3 2020.

Based on Carillon Tower Advisers's 13F filing for Q3 2020, filed 12 Nov 2020.